Hope S Rugo (Hope Rugo, H S Rugo)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 132

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

NPJ breast cancer

Clinical cancer research : an official journal of the American Association for Cancer Research

Breast cancer research and treatment

This page only lists publications with an associated author ORCID identifier.

Publications

Maggie Chon U Cheang, Mothaffar F Rimawi, Stephen Johnston, Samuel A Jacobs, Judith Bliss, Katherine Pogue-Geile, Lucy Kilburn, Zhou Zhu, Eugene F Schuster, Hui Xiao, Lisa Swaim, Shibing Deng, Dongrui R Lu, Eric Gauthier, Jennifer Tursi, Dennis J Slamon, Hope S Rugo, Richard S Finn, Yuan Liu
Effect of cross-platform gene-expression, computational methods on breast cancer subtyping in PALOMA-2 and PALLET studies. NPJ breast cancer 10 (1) (2024)
Dennis J Slamon, Véronique Diéras, Hope S Rugo, Nadia Harbeck, Seock-Ah Im, Karen A Gelmon, Oleg N Lipatov, Janice M Walshe, Miguel Martin, Mariana Chavez Mac Gregor, Eustratios Bananis, Eric Gauthier, Dongrui Ray Lu, Sindy Kim, Richard S Finn
Overall Survival With Palbociclib Plus Letrozole in Advanced Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (9) (2024)
Aditya Bardia, Hope S Rugo, Sara M Tolaney, Delphine Loirat, Kevin Punie, Mafalda Oliveira, Adam M Brufsky, Kevin M Kalinsky, Javier Cortes, Joyce O' Shaughnessy, Véronique Diéras, Lisa Anne Carey, Luca Gianni, Martine J Piccart, Sibylle Loibl, Oh Kyu Yoon, Yang Pan, Scott Hofsess, See-Chun Phan, Sara Alsterlind Hurvitz
Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (15) (2024)
Daniel G Stover, Roberto Salgado, Oleksander Savenkov, Karla Ballman, Erica L Mayer, Mark Jesus M Magbanua, Sherene Loi, Mark Vater, Kristyn Glover, Mark Watson, Yujia Wen, William Fraser Symmans, Charles M Perou, Lisa Anne Carey, Ann H Partridge, Hope S Rugo
Association between tumor-infiltrating lymphocytes and survival in patients with metastatic breast cancer receiving first-line chemotherapy: analysis of CALGB 40502. NPJ breast cancer 10 (1) (2024)
Sana A Al Sukhun, Sarah Temin, Carlos Henrique Barrios, Nicoleta Zenovia Antone, Yanin Chavarri Guerra, Mariana Chavez Mac Gregor, Rakesh Chopra, Michael A Danso, Henry Leonidas Gomez, N'Da Marcelin Homian, Alaa Kandil, Benda Kithaka, Bogda Koczwara, Beverly Moy, Gertrude Nakigudde, Fernando Enrique Petracci, Hope S Rugo, Nagi S El Saghir, Banu K Arun
Systemic Treatment of Patients With Metastatic Breast Cancer: ASCO Resource-Stratified Guideline. JCO global oncology 10 (2024)
Paolo Tarantino, Nabihah Tayob, Guillermo Villacampa, Chau Dang, Denise A Yardley, Steven Jay Isakoff, Vicente Valero, Meredith Faggen, Therese Marie Mulvey, Ron Bose, Douglas Weckstein, Antonio C Wolff, Katherine E Reeder-Hayes, Hope S Rugo, Bhuvaneswari Ramaswamy, Dan Zuckerman, Lowell Hart, Vijayakrishna K Gadi, Michael Constantine, Kit Cheng, Audrey Merrill Garrett, P Kelly Marcom, Kathy S Albain, Patricia DeFusco, Nadine M Tung, Blair Ardman, Rita Nanda, Rachel C Jankowitz, Mothaffar F Rimawi, Vandana G Abramson, Paula R Pohlmann, Catherine H Van Poznak, Andres Forero-Torres, Minetta C Liu, Kathryn J Ruddy, Adrienne G Waks, Michelle DeMeo, Harold J Burstein, Ann H Partridge, Patrizia Dell'Orto, Leila Russo, Emma Krause, Daniel J Newhouse, Busem Binboğa Kurt, Elizabeth A Mittendorf, Bryan Paul Schneider, Adrienne G Waks, Eric P Winer, Ian E Krop, Sara M Tolaney, null null, null null
Adjuvant Trastuzumab Emtansine Versus Paclitaxel Plus Trastuzumab for Stage I Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: 5-Year Results and Correlative Analyses From ATEMPT. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Toru Mukohara, Yeon Hee Park, David Sommerhalder, Kan Yonemori, Erika Paige Hamilton, Sung-Bae Kim, Jee Hyun Kim, Hiroji Iwata, Toshinari Yamashita, Rachel M Layman, Monica Mita, Timothy Clay, Yee Soo Chae, Catherine Oakman, Fengting Yan, Gun Min Kim, Seock-Ah Im, Geoffrey J Lindeman, Hope S Rugo, Marlon Liyanage, Michelle Saul, Christophe Le Corre, Athanasia Skoura, Li Liu, Meng Li, Patricia M LoRusso
Author Correction: Inhibition of lysine acetyltransferase KAT6 in ER + HER2 - metastatic breast cancer: a phase 1 trial. Nature medicine (2024)
Javier Cortes, Sara Alsterlind Hurvitz, Joyce O'Shaughnessy, Suzette Delaloge, Hiroji Iwata, Hope S Rugo, Patrick Neven, Dheepak Kanagavel, Patrick Cohen, Gautier Paux, Sylvaine Cartot-Cotton, Maya Stefanova-Urena, Laure Deyme, Jihane Aouni, Bernard Sebastien, Aditya Bardia
Randomized Phase III Study of Amcenestrant Plus Palbociclib Versus Letrozole Plus Palbociclib in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Primary Results From AMEERA-5. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Rebecca A Shatsky, Meghna S Trivedi, Christina Yau, Rita Nanda, Hope S Rugo, Marie Davidian, Butch Tsiatis, Anne M Wallace, A Jo Chien, Erica Stringer-Reasor, Judy C Boughey, Coral Omene, Mariya Rozenblit, Kevin M Kalinsky, Anthony D Elias, Christos Vaklavas, Heather Beckwith, Nicole Williams, Mili Arora, Chaitali Nangia, Evanthia T Roussos Torres, Brittani Thomas, Kathy S Albain, Amy S Clark, Carla Falkson, Dawn L Hershman, Claudine Isaacs, Alexandra Thomas, Jennifer Tseng, Amy Sanford, Kay Yeung, Sarah Boles, Yunni Yi Chen, Laura Huppert, Nusrat Jahan, Catherine Parker, Karthik Giridhar, Frederick M Howard, M Michele Blackwood, Tara Sanft, Wen Li, Natsuko Onishi, Adam L Asare, Philip Beineke, Peter Norwood, Lamorna Brown Swigart, Gillian L Hirst, Jeffrey B Matthews, Brian Moore, William Fraser Symmans, Elissa Price, Diane Heditsian, Barbara LeStage, Jane Perlmutter, Paula R Pohlmann, Angela M DeMichele, Douglas Yee, Laura van 't Veer, Nola M Hylton, Laura J Esserman
Datopotamab-deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial. Nature medicine (2024)
Aditya Bardia, Komal L Jhaveri, Seock-Ah Im, Sonia Pernas, Michelino De Laurentiis, Shu-Sen Wang, Noelia Martínez Jañez, Giuliano Borges, David W Cescon, Masaya Hattori, Yen-Shen Lu, Erika Paige Hamilton, Qingyuan Zhang, Junji Tsurutani, Kevin M Kalinsky, Pedro Emanuel Rubini Liedke, Lu Xu, Rick M Fairhurst, Sabrina Khan, Neelima Denduluri, Hope S Rugo, Binghe Xu, Barbara Pistilli, null null
Datopotamab Deruxtecan Versus Chemotherapy in Previously Treated Inoperable/Metastatic Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: Primary Results From TROPION-Breast01. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Dennis J Slamon, Véronique Diéras, Hope S Rugo, Nadia Harbeck, Seock-Ah Im, Karen A Gelmon, Oleg N Lipatov, Janice M Walshe, Miguel Martin, Mariana Chavez Mac Gregor, Eustratios Bananis, Eric Gauthier, Dongrui Ray Lu, Sindy Kim, Richard S Finn
Overall Survival With Palbociclib Plus Letrozole in Advanced Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (9) (2024)
Kathy S Albain, Christina Yau, Emanuel F Petricoin, Denise M Wolf, Julie E Lang, Amy Jo Chien, Tufia C Haddad, Andres Forero-Torres, Anne M Wallace, Henry G Kaplan, Lajos Pusztai, David M Euhus, Rita Nanda, Anthony D Elias, Amy S Clark, Constantine Godellas, Judy C Boughey, Claudine Isaacs, Debasish Tripathy, Janice Lu, Rachel L Yung, Rosa I Gallagher, Julia D Wulfkuhle, Lamorna Brown Swigart, Gregor Krings, Yunn Yi Chen, David A Potter, Erica M Stringer-Reasor, Sarah L Blair, Smita M Asare, Amy Wilson, Gillian L Hirst, Ruby Singhrao, Meredith Buxton, Julia L Clennell, Ashish Sanil, Scott Berry, Adam L Asare, Jeffrey B Matthews, Angela M DeMichele, Nola M Hylton, Michelle E Melisko, Jane Perlmutter, Hope S Rugo, William Fraser Symmans, Laura van 't Veer, Douglas Yee, Donald A Berry, Laura J Esserman
Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (4) (2024)
Katia Khoury, Jane L Meisel, Christina Yau, Hope S Rugo, Rita Nanda, Marie Davidian, Butch Tsiatis, A Jo Chien, Anne M Wallace, Mili Arora, Mariya Rozenblit, Dawn L Hershman, Alexandra S Zimmer, Amy S Clark, Heather Beckwith, Anthony D Elias, Erica Stringer-Reasor, Judy C Boughey, Chaitali Nangia, Christos Vaklavas, Coral Omene, Kathy S Albain, Kevin M Kalinsky, Claudine Isaacs, Jennifer Tseng, Evanthia T Roussos Torres, Brittani Thomas, Alexandra Thomas, Amy Sanford, Ronald Balassanian, Cheryl Ewing, Kay Yeung, Candice A M Sauder, Tara Sanft, Lajos Pusztai, Meghna S Trivedi, Ashton Outhaythip, Wen Li, Natsuko Onishi, Adam L Asare, Philip Beineke, Peter Norwood, Lamorna Brown Swigart, Gillian L Hirst, Jeffrey B Matthews, Brian Moore, W Fraser Symmans, Elissa Price, Carolyn Beedle, Jane Perlmutter, Paula R Pohlmann, Rebecca A Shatsky, Angela M DeMichele, Douglas Yee, Laura van 't Veer, Nola M Hylton, Laura J Esserman
Datopotamab-deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial. Nature medicine (2024)
Sara Alsterlind Hurvitz, Aditya Bardia, Kevin Punie, Kevin M Kalinsky, Lisa Anne Carey, Hope S Rugo, Véronique Diéras, See Phan, Rosemary Delaney, Yanni Zhu, Sara M Tolaney
Subgroup analyses from the phase 3 ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancer. NPJ breast cancer 10 (1) (2024)
Aditya Bardia, Hope S Rugo, Sara M Tolaney, Delphine Loirat, Kevin Punie, Mafalda Oliveira, Adam M Brufsky, Kevin M Kalinsky, Javier Cortes, Joyce O' Shaughnessy, Véronique Diéras, Lisa Anne Carey, Luca Gianni, Martine J Piccart, Sibylle Loibl, Oh Kyu Yoon, Yang Pan, Scott Hofsess, See-Chun Phan, Sara Alsterlind Hurvitz
Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (15) (2024)
Sara Alsterlind Hurvitz, Aditya Bardia, Kevin Punie, Kevin M Kalinsky, Lisa Anne Carey, Hope S Rugo, Véronique Diéras, See Phan, Rosemary Delaney, Yanni Zhu, Sara M Tolaney
Subgroup analyses from the phase 3 ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancer. NPJ breast cancer 10 (1) (2024)
Toru Mukohara, Yeon Hee Park, David Sommerhalder, Kan Yonemori, Erika Paige Hamilton, Sung-Bae Kim, Jee Hyun Kim, Hiroji Iwata, Toshinari Yamashita, Rachel M Layman, Monica Mita, Timothy Clay, Yee Soo Chae, Catherine Oakman, Fengting Yan, Gun Min Kim, Seock-Ah Im, Geoffrey J Lindeman, Hope S Rugo, Marlon Liyanage, Michelle Saul, Christophe Le Corre, Athanasia Skoura, Li Liu, Meng Li, Patricia M LoRusso
Inhibition of lysine acetyltransferase KAT6 in ER + HER2 - metastatic breast cancer: a phase 1 trial. Nature medicine 30 (8) (2024)
Priya Rastogi, Joyce O'Shaughnessy, Miguel Martin, Frances M Boyle, Javier Cortes, Hope S Rugo, Matthew P Goetz, Erika Paige Hamilton, Chiun-Sheng Huang, Elzbieta Senkus, Alexey A Tryakin, Irfan Cicin, Laura Testa, Patrick Neven, Jens Huober, Zhi-Ming Shao, Ran Wei, Valérie André, Maria Munoz, Belen San Antonio, Ashwin Shahir, Nadia Harbeck, Stephen R D Johnston
Adjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (9) (2024)
Dennis J Slamon, Véronique Diéras, Hope S Rugo, Nadia Harbeck, Seock-Ah Im, Karen A Gelmon, Oleg N Lipatov, Janice M Walshe, Miguel Martin, Mariana Chavez Mac Gregor, Eustratios Bananis, Eric Gauthier, Dongrui Ray Lu, Sindy Kim, Richard S Finn
Overall Survival With Palbociclib Plus Letrozole in Advanced Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Sara Alsterlind Hurvitz, Aditya Bardia, Kevin Punie, Kevin M Kalinsky, Lisa Anne Carey, Hope S Rugo, Véronique Diéras, See Phan, Rosemary Delaney, Yanni Zhu, Sara M Tolaney
Subgroup analyses from the phase 3 ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancer. NPJ breast cancer 10 (1) (2024)
Maggie Chon U Cheang, Mothaffar F Rimawi, Stephen Johnston, Samuel A Jacobs, Judith Bliss, Katherine Pogue-Geile, Lucy Kilburn, Zhou Zhu, Eugene F Schuster, Hui Xiao, Lisa Swaim, Shibing Deng, Dongrui R Lu, Eric Gauthier, Jennifer Tursi, Dennis J Slamon, Hope S Rugo, Richard S Finn, Yuan Liu
Effect of cross-platform gene-expression, computational methods on breast cancer subtyping in PALOMA-2 and PALLET studies. NPJ breast cancer 10 (1) (2024)
Aditya Bardia, Hope S Rugo, Sara M Tolaney, Delphine Loirat, Kevin Punie, Mafalda Oliveira, Adam M Brufsky, Kevin M Kalinsky, Javier Cortes, Joyce O' Shaughnessy, Véronique Diéras, Lisa Anne Carey, Luca Gianni, Martine J Piccart, Sibylle Loibl, Oh Kyu Yoon, Yang Pan, Scott Hofsess, See-Chun Phan, Sara Alsterlind Hurvitz
Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Priya Rastogi, Joyce O'Shaughnessy, Miguel Martin, Frances M Boyle, Javier Cortes, Hope S Rugo, Matthew P Goetz, Erika Paige Hamilton, Chiun-Sheng Huang, Elzbieta Senkus, Alexey A Tryakin, Irfan Cicin, Laura Testa, Patrick Neven, Jens Huober, Zhi-Ming Shao, Ran Wei, Valérie André, Maria Munoz, Belen San Antonio, Ashwin Shahir, Nadia Harbeck, Stephen R D Johnston
Adjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (9) (2024)
Hope S Rugo, Sara M Tolaney, Delphine Loirat, Kevin Punie, Aditya Bardia, Sara Alsterlind Hurvitz, Joyce O'Shaughnessy, Javier Cortes, Véronique Diéras, Lisa Anne Carey, Luca Gianni, Martine J Piccart, Sibylle Loibl, David M Goldenberg, Quan Hong, Martin Olivo, Loretta M Itri, Kevin Kalinsky
Author Correction: Safety analyses from the phase 3 ASCENT trial of sacituzumab govitecan in metastatic triple-negative breast cancer. NPJ breast cancer 10 (1) (2024)
Daniel G Stover, Roberto Salgado, Oleksander Savenkov, Karla Ballman, Erica L Mayer, Mark Jesus M Magbanua, Sherene Loi, Mark Vater, Kristyn Glover, Mark Watson, Yujia Wen, William Fraser Symmans, Charles M Perou, Lisa Anne Carey, Ann H Partridge, Hope S Rugo
Association between tumor-infiltrating lymphocytes and survival in patients with metastatic breast cancer receiving first-line chemotherapy: analysis of CALGB 40502. NPJ breast cancer 10 (1) (2024)
Maggie Chon U Cheang, Mothaffar F Rimawi, Stephen Johnston, Samuel A Jacobs, Judith Bliss, Katherine Pogue-Geile, Lucy Kilburn, Zhou Zhu, Eugene F Schuster, Hui Xiao, Lisa Swaim, Shibing Deng, Dongrui R Lu, Eric Gauthier, Jennifer Tursi, Dennis J Slamon, Hope S Rugo, Richard S Finn, Yuan Liu
Effect of cross-platform gene-expression, computational methods on breast cancer subtyping in PALOMA-2 and PALLET studies. NPJ breast cancer 10 (1) (2024)
Toru Mukohara, Yeon Hee Park, David Sommerhalder, Kan Yonemori, Erika Paige Hamilton, Sung-Bae Kim, Jee Hyun Kim, Hiroji Iwata, Toshinari Yamashita, Rachel M Layman, Monica Mita, Timothy Clay, Yee Soo Chae, Catherine Oakman, Fengting Yan, Gun Min Kim, Seock-Ah Im, Geoffrey J Lindeman, Hope S Rugo, Marlon Liyanage, Michelle Saul, Christophe Le Corre, Athanasia Skoura, Li Liu, Meng Li, Patricia M LoRusso
Inhibition of lysine acetyltransferase KAT6 in ER + HER2 - metastatic breast cancer: a phase 1 trial. Nature medicine (2024)
Hope S Rugo, Peter Schmid, Sara M Tolaney, Florence Dalenc, Frederic Marmé, Ling Shi, Wendy Verret, Anuj Shah, Mahdi Gharaibeh, Aditya Bardia, Javier Cortes
Health-related quality of life with sacituzumab govitecan in HR+/HER2- metastatic breast cancer in the phase III TROPiCS-02 trial. The oncologist (2024)
Maggie Chon U Cheang, Mothaffar F Rimawi, Stephen Johnston, Samuel A Jacobs, Judith Bliss, Katherine Pogue-Geile, Lucy Kilburn, Zhou Zhu, Eugene F Schuster, Hui Xiao, Lisa Swaim, Shibing Deng, Dongrui R Lu, Eric Gauthier, Jennifer Tursi, Dennis J Slamon, Hope S Rugo, Richard S Finn, Yuan Liu
Effect of cross-platform gene-expression, computational methods on breast cancer subtyping in PALOMA-2 and PALLET studies. NPJ breast cancer 10 (1) (2024)
Sara Alsterlind Hurvitz, Aditya Bardia, Kevin Punie, Kevin M Kalinsky, Lisa Anne Carey, Hope S Rugo, Véronique Diéras, See Phan, Rosemary Delaney, Yanni Zhu, Sara M Tolaney
Author Correction: Subgroup analyses from the phase 3 ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancer. NPJ breast cancer 10 (1) (2024)
Toru Mukohara, Yeon Hee Park, David Sommerhalder, Kan Yonemori, Erika Paige Hamilton, Sung-Bae Kim, Jee Hyun Kim, Hiroji Iwata, Toshinari Yamashita, Rachel M Layman, Monica Mita, Timothy Clay, Yee Soo Chae, Catherine Oakman, Fengting Yan, Gun Min Kim, Seock-Ah Im, Geoffrey J Lindeman, Hope S Rugo, Marlon Liyanage, Michelle Saul, Christophe Le Corre, Athanasia Skoura, Li Liu, Meng Li, Patricia M LoRusso
Author Correction: Inhibition of lysine acetyltransferase KAT6 in ER + HER2 - metastatic breast cancer: a phase 1 trial. Nature medicine (2024)
Priya Rastogi, Joyce O'Shaughnessy, Miguel Martin, Frances M Boyle, Javier Cortes, Hope S Rugo, Matthew P Goetz, Erika Paige Hamilton, Chiun-Sheng Huang, Elzbieta Senkus, Alexey A Tryakin, Irfan Cicin, Laura Testa, Patrick Neven, Jens Huober, Zhi-Ming Shao, Ran Wei, Valérie André, Maria Munoz, Belen San Antonio, Ashwin Shahir, Nadia Harbeck, Stephen R D Johnston
Adjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (9) (2024)
Toru Mukohara, Yeon Hee Park, David Sommerhalder, Kan Yonemori, Erika Paige Hamilton, Sung-Bae Kim, Jee Hyun Kim, Hiroji Iwata, Toshinari Yamashita, Rachel M Layman, Monica Mita, Timothy Clay, Yee Soo Chae, Catherine Oakman, Fengting Yan, Gun Min Kim, Seock-Ah Im, Geoffrey J Lindeman, Hope S Rugo, Marlon Liyanage, Michelle Saul, Christophe Le Corre, Athanasia Skoura, Li Liu, Meng Li, Patricia M LoRusso
Inhibition of lysine acetyltransferase KAT6 in ER + HER2 - metastatic breast cancer: a phase 1 trial. Nature medicine (2024)
Sana A Al Sukhun, Sarah Temin, Carlos Henrique Barrios, Nicoleta Zenovia Antone, Yanin Chavarri Guerra, Mariana Chavez Mac Gregor, Rakesh Chopra, Michael A Danso, Henry Leonidas Gomez, N'Da Marcelin Homian, Alaa Kandil, Benda Kithaka, Bogda Koczwara, Beverly Moy, Gertrude Nakigudde, Fernando Enrique Petracci, Hope S Rugo, Nagi S El Saghir, Banu K Arun
Systemic Treatment of Patients With Metastatic Breast Cancer: ASCO Resource-Stratified Guideline. JCO global oncology 10 (2024)
Sara Alsterlind Hurvitz, Aditya Bardia, Kevin Punie, Kevin M Kalinsky, Lisa Anne Carey, Hope S Rugo, Véronique Diéras, See Phan, Rosemary Delaney, Yanni Zhu, Sara M Tolaney
Subgroup analyses from the phase 3 ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancer. NPJ breast cancer 10 (1) (2024)
Seock-Ah Im, Javier Cortes, David W Cescon, Mastura Md Yusof, Hiroji Iwata, Norikazu Masuda, Toshimi Takano, Chiun-Sheng Huang, Chi-Feng Chung, Koichiro Tsugawa, Yeon Hee Park, Koji Matsumoto, Kenichi Inoue, Ava Kwong, Sherene Loi, Wei Fu, Wilbur Pan, Vassiliki Karantza, Hope S Rugo, Peter Schmid
Results from the randomized KEYNOTE-355 study of pembrolizumab plus chemotherapy for Asian patients with advanced TNBC. NPJ breast cancer 10 (1) (2024)
Dennis J Slamon, Véronique Diéras, Hope S Rugo, Nadia Harbeck, Seock-Ah Im, Karen A Gelmon, Oleg N Lipatov, Janice M Walshe, Miguel Martin, Mariana Chavez Mac Gregor, Eustratios Bananis, Eric Gauthier, Dongrui Ray Lu, Sindy Kim, Richard S Finn
Overall Survival With Palbociclib Plus Letrozole in Advanced Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (9) (2024)
Priya Rastogi, Joyce O'Shaughnessy, Miguel Martin, Frances M Boyle, Javier Cortes, Hope S Rugo, Matthew P Goetz, Erika Paige Hamilton, Chiun-Sheng Huang, Elzbieta Senkus, Alexey A Tryakin, Irfan Cicin, Laura Testa, Patrick Neven, Jens Huober, Zhi-Ming Shao, Ran Wei, Valérie André, Maria Munoz, Belen San Antonio, Ashwin Shahir, Nadia Harbeck, Stephen R D Johnston
Adjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Aditya Bardia, Hope S Rugo, Sara M Tolaney, Delphine Loirat, Kevin Punie, Mafalda Oliveira, Adam M Brufsky, Kevin M Kalinsky, Javier Cortes, Joyce O' Shaughnessy, Véronique Diéras, Lisa Anne Carey, Luca Gianni, Martine J Piccart, Sibylle Loibl, Oh Kyu Yoon, Yang Pan, Scott Hofsess, See-Chun Phan, Sara Alsterlind Hurvitz
Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (15) (2024)
Sara Alsterlind Hurvitz, Aditya Bardia, Kevin Punie, Kevin M Kalinsky, Lisa Anne Carey, Hope S Rugo, Véronique Diéras, See Phan, Rosemary Delaney, Yanni Zhu, Sara M Tolaney
Subgroup analyses from the phase 3 ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancer. NPJ breast cancer 10 (1) (2024)
Sara Alsterlind Hurvitz, Aditya Bardia, Kevin Punie, Kevin M Kalinsky, Lisa Anne Carey, Hope S Rugo, Véronique Diéras, See Phan, Rosemary Delaney, Yanni Zhu, Sara M Tolaney
Author Correction: Subgroup analyses from the phase 3 ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancer. NPJ breast cancer 10 (1) (2024)
Javier Cortes, Sara Alsterlind Hurvitz, Joyce O'Shaughnessy, Suzette Delaloge, Hiroji Iwata, Hope S Rugo, Patrick Neven, Dheepak Kanagavel, Patrick Cohen, Gautier Paux, Sylvaine Cartot-Cotton, Maya Stefanova-Urena, Laure Deyme, Jihane Aouni, Bernard Sebastien, Aditya Bardia
Randomized Phase III Study of Amcenestrant Plus Palbociclib Versus Letrozole Plus Palbociclib in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Primary Results From AMEERA-5. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (22) (2024)
Kathy S Albain, Christina Yau, Emanuel F Petricoin, Denise M Wolf, Julie E Lang, Amy Jo Chien, Tufia C Haddad, Andres Forero-Torres, Anne M Wallace, Henry G Kaplan, Lajos Pusztai, David M Euhus, Rita Nanda, Anthony D Elias, Amy S Clark, Constantine Godellas, Judy C Boughey, Claudine Isaacs, Debasish Tripathy, Janice Lu, Rachel L Yung, Rosa I Gallagher, Julia D Wulfkuhle, Lamorna Brown Swigart, Gregor Krings, Yunn Yi Chen, David A Potter, Erica M Stringer-Reasor, Sarah L Blair, Smita M Asare, Amy Wilson, Gillian L Hirst, Ruby Singhrao, Meredith Buxton, Julia L Clennell, Ashish Sanil, Scott Berry, Adam L Asare, Jeffrey B Matthews, Angela M DeMichele, Nola M Hylton, Michelle E Melisko, Jane Perlmutter, Hope S Rugo, William Fraser Symmans, Laura van 't Veer, Douglas Yee, Donald A Berry, Laura J Esserman
Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (4) (2024)
Aditya Bardia, Hope S Rugo, Sara M Tolaney, Delphine Loirat, Kevin Punie, Mafalda Oliveira, Adam M Brufsky, Kevin M Kalinsky, Javier Cortes, Joyce O' Shaughnessy, Véronique Diéras, Lisa Anne Carey, Luca Gianni, Martine J Piccart, Sibylle Loibl, Oh Kyu Yoon, Yang Pan, Scott Hofsess, See-Chun Phan, Sara Alsterlind Hurvitz
Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (15) (2024)
Dennis J Slamon, Véronique Diéras, Hope S Rugo, Nadia Harbeck, Seock-Ah Im, Karen A Gelmon, Oleg N Lipatov, Janice M Walshe, Miguel Martin, Mariana Chavez Mac Gregor, Eustratios Bananis, Eric Gauthier, Dongrui Ray Lu, Sindy Kim, Richard S Finn
Overall Survival With Palbociclib Plus Letrozole in Advanced Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Priya Rastogi, Joyce O'Shaughnessy, Miguel Martin, Frances M Boyle, Javier Cortes, Hope S Rugo, Matthew P Goetz, Erika Paige Hamilton, Chiun-Sheng Huang, Elzbieta Senkus, Alexey A Tryakin, Irfan Cicin, Laura Testa, Patrick Neven, Jens Huober, Zhi-Ming Shao, Ran Wei, Valérie André, Maria Munoz, Belen San Antonio, Ashwin Shahir, Nadia Harbeck, Stephen R D Johnston
Adjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (9) (2024)
Sana A Al Sukhun, Sarah Temin, Carlos Henrique Barrios, Nicoleta Zenovia Antone, Yanin Chavarri Guerra, Mariana Chavez Mac Gregor, Rakesh Chopra, Michael A Danso, Henry Leonidas Gomez, N'Da Marcelin Homian, Alaa Kandil, Benda Kithaka, Bogda Koczwara, Beverly Moy, Gertrude Nakigudde, Fernando Enrique Petracci, Hope S Rugo, Nagi S El Saghir, Banu K Arun
Systemic Treatment of Patients With Metastatic Breast Cancer: ASCO Resource-Stratified Guideline. JCO global oncology 10 (2024)
Maggie Chon U Cheang, Mothaffar F Rimawi, Stephen Johnston, Samuel A Jacobs, Judith Bliss, Katherine Pogue-Geile, Lucy Kilburn, Zhou Zhu, Eugene F Schuster, Hui Xiao, Lisa Swaim, Shibing Deng, Dongrui R Lu, Eric Gauthier, Jennifer Tursi, Dennis J Slamon, Hope S Rugo, Richard S Finn, Yuan Liu
Effect of cross-platform gene-expression, computational methods on breast cancer subtyping in PALOMA-2 and PALLET studies. NPJ breast cancer 10 (1) (2024)
Toru Mukohara, Yeon Hee Park, David Sommerhalder, Kan Yonemori, Erika Paige Hamilton, Sung-Bae Kim, Jee Hyun Kim, Hiroji Iwata, Toshinari Yamashita, Rachel M Layman, Monica Mita, Timothy Clay, Yee Soo Chae, Catherine Oakman, Fengting Yan, Gun Min Kim, Seock-Ah Im, Geoffrey J Lindeman, Hope S Rugo, Marlon Liyanage, Michelle Saul, Christophe Le Corre, Athanasia Skoura, Li Liu, Meng Li, Patricia M LoRusso
Inhibition of lysine acetyltransferase KAT6 in ER + HER2 - metastatic breast cancer: a phase 1 trial. Nature medicine 30 (8) (2024)
Sara Alsterlind Hurvitz, Aditya Bardia, Kevin Punie, Kevin M Kalinsky, Lisa Anne Carey, Hope S Rugo, Véronique Diéras, See Phan, Rosemary Delaney, Yanni Zhu, Sara M Tolaney
Subgroup analyses from the phase 3 ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancer. NPJ breast cancer 10 (1) (2024)
Mark Jesus M Magbanua, Ziad Ahmed, Rosalyn W Sayaman, Lamorna Brown Swigart, Gillian L Hirst, Christina Yau, Denise M Wolf, Wen Li, Amy L Delson, Jane Perlmutter, Paula R Pohlmann, William Fraser Symmans, Douglas Yee, Nola M Hylton, Laura J Esserman, Angela M DeMichele, Hope S Rugo, Laura van 't Veer
Cell-free DNA Concentration as a Biomarker of Response and Recurrence in HER2-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Mark Jesus M Magbanua, Ziad Ahmed, Rosalyn W Sayaman, Lamorna Brown Swigart, Gillian L Hirst, Christina Yau, Denise M Wolf, Wen Li, Amy L Delson, Jane Perlmutter, Paula R Pohlmann, William Fraser Symmans, Douglas Yee, Nola M Hylton, Laura J Esserman, Angela M DeMichele, Hope S Rugo, Laura van 't Veer
Cell-free DNA Concentration as a Biomarker of Response and Recurrence in HER2-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Toru Mukohara, Yeon Hee Park, David Sommerhalder, Kan Yonemori, Erika Paige Hamilton, Sung-Bae Kim, Jee Hyun Kim, Hiroji Iwata, Toshinari Yamashita, Rachel M Layman, Monica Mita, Timothy Clay, Yee Soo Chae, Catherine Oakman, Fengting Yan, Gun Min Kim, Seock-Ah Im, Geoffrey J Lindeman, Hope S Rugo, Marlon Liyanage, Michelle Saul, Christophe Le Corre, Athanasia Skoura, Li Liu, Meng Li, Patricia M LoRusso
Inhibition of lysine acetyltransferase KAT6 in ER + HER2 - metastatic breast cancer: a phase 1 trial. Nature medicine 30 (8) (2024)
Mark Jesus M Magbanua, Ziad Ahmed, Rosalyn W Sayaman, Lamorna Brown Swigart, Gillian L Hirst, Christina Yau, Denise M Wolf, Wen Li, Amy L Delson, Jane Perlmutter, Paula R Pohlmann, William Fraser Symmans, Douglas Yee, Nola M Hylton, Laura J Esserman, Angela M DeMichele, Hope S Rugo, Laura van 't Veer
Cell-free DNA Concentration as a Biomarker of Response and Recurrence in HER2-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Priya Rastogi, Joyce O'Shaughnessy, Miguel Martin, Frances M Boyle, Javier Cortes, Hope S Rugo, Matthew P Goetz, Erika Paige Hamilton, Chiun-Sheng Huang, Elzbieta Senkus, Alexey A Tryakin, Irfan Cicin, Laura Testa, Patrick Neven, Jens Huober, Zhi-Ming Shao, Ran Wei, Valérie André, Maria Munoz, Belen San Antonio, Ashwin Shahir, Nadia Harbeck, Stephen R D Johnston
Adjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (9) (2024)
Toru Mukohara, Yeon Hee Park, David Sommerhalder, Kan Yonemori, Erika Paige Hamilton, Sung-Bae Kim, Jee Hyun Kim, Hiroji Iwata, Toshinari Yamashita, Rachel M Layman, Monica Mita, Timothy Clay, Yee Soo Chae, Catherine Oakman, Fengting Yan, Gun Min Kim, Seock-Ah Im, Geoffrey J Lindeman, Hope S Rugo, Marlon Liyanage, Michelle Saul, Christophe Le Corre, Athanasia Skoura, Li Liu, Meng Li, Patricia M LoRusso
Inhibition of lysine acetyltransferase KAT6 in ER + HER2 - metastatic breast cancer: a phase 1 trial. Nature medicine (2024)
Kathy S Albain, Christina Yau, Emanuel F Petricoin, Denise M Wolf, Julie E Lang, Amy Jo Chien, Tufia C Haddad, Andres Forero-Torres, Anne M Wallace, Henry G Kaplan, Lajos Pusztai, David M Euhus, Rita Nanda, Anthony D Elias, Amy S Clark, Constantine Godellas, Judy C Boughey, Claudine Isaacs, Debasish Tripathy, Janice Lu, Rachel L Yung, Rosa I Gallagher, Julia D Wulfkuhle, Lamorna Brown Swigart, Gregor Krings, Yunn Yi Chen, David A Potter, Erica M Stringer-Reasor, Sarah L Blair, Smita M Asare, Amy Wilson, Gillian L Hirst, Ruby Singhrao, Meredith Buxton, Julia L Clennell, Ashish Sanil, Scott Berry, Adam L Asare, Jeffrey B Matthews, Angela M DeMichele, Nola M Hylton, Michelle E Melisko, Jane Perlmutter, Hope S Rugo, William Fraser Symmans, Laura van 't Veer, Douglas Yee, Donald A Berry, Laura J Esserman
Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (4) (2024)
Mark Jesus M Magbanua, Ziad Ahmed, Rosalyn W Sayaman, Lamorna Brown Swigart, Gillian L Hirst, Christina Yau, Denise M Wolf, Wen Li, Amy L Delson, Jane Perlmutter, Paula R Pohlmann, William Fraser Symmans, Douglas Yee, Nola M Hylton, Laura J Esserman, Angela M DeMichele, Hope S Rugo, Laura van 't Veer
Cell-free DNA Concentration as a Biomarker of Response and Recurrence in HER2-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Kathy S Albain, Christina Yau, Emanuel F Petricoin, Denise M Wolf, Julie E Lang, Amy Jo Chien, Tufia C Haddad, Andres Forero-Torres, Anne M Wallace, Henry G Kaplan, Lajos Pusztai, David M Euhus, Rita Nanda, Anthony D Elias, Amy S Clark, Constantine Godellas, Judy C Boughey, Claudine Isaacs, Debasish Tripathy, Janice Lu, Rachel L Yung, Rosa I Gallagher, Julia D Wulfkuhle, Lamorna Brown Swigart, Gregor Krings, Yunn Yi Chen, David A Potter, Erica M Stringer-Reasor, Sarah L Blair, Smita M Asare, Amy Wilson, Gillian L Hirst, Ruby Singhrao, Meredith Buxton, Julia L Clennell, Ashish Sanil, Scott Berry, Adam L Asare, Jeffrey B Matthews, Angela M DeMichele, Nola M Hylton, Michelle E Melisko, Jane Perlmutter, Hope S Rugo, William Fraser Symmans, Laura van 't Veer, Douglas Yee, Donald A Berry, Laura J Esserman
Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (4) (2024)
Anne Loeser, Janice S Kim, Jeffrey M Peppercorn, Mark E Burkard, Andrzej Niemierko, Dejan Juric, Kevin M Kalinsky, Hope S Rugo, Lesley Glenn, Christine Hodgdon, Julia Maués, Sheila Johnson, Natalia Padron, Kimberly Parekh, Maryam B Lustberg, Aditya Bardia
The Right Dose: Results of a Patient Advocate-Led Survey of Individuals With Metastatic Breast Cancer Regarding Treatment-Related Side Effects and Views About Dosage Assessment to Optimize Quality of Life. JCO oncology practice (2024)
Dennis J Slamon, Véronique Diéras, Hope S Rugo, Nadia Harbeck, Seock-Ah Im, Karen A Gelmon, Oleg N Lipatov, Janice M Walshe, Miguel Martin, Mariana Chavez Mac Gregor, Eustratios Bananis, Eric Gauthier, Dongrui Ray Lu, Sindy Kim, Richard S Finn
Overall Survival With Palbociclib Plus Letrozole in Advanced Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (9) (2024)
Matthew P Goetz, Irfan Cicin, Laura Testa, Sara M Tolaney, Jens Huober, Valentina Guarneri, Stephen R D Johnston, Miguel Martin, Priya Rastogi, Nadia Harbeck, Ashwin Shahir, Ran Wei, Valérie André, Hope S Rugo, Joyce O'Shaughnessy
Impact of dose reductions on adjuvant abemaciclib efficacy for patients with high-risk early breast cancer: analyses from the monarchE study. NPJ breast cancer 10 (1) (2024)
Kathy S Albain, Christina Yau, Emanuel F Petricoin, Denise M Wolf, Julie E Lang, Amy Jo Chien, Tufia C Haddad, Andres Forero-Torres, Anne M Wallace, Henry G Kaplan, Lajos Pusztai, David M Euhus, Rita Nanda, Anthony D Elias, Amy S Clark, Constantine Godellas, Judy C Boughey, Claudine Isaacs, Debasish Tripathy, Janice Lu, Rachel L Yung, Rosa I Gallagher, Julia D Wulfkuhle, Lamorna Brown Swigart, Gregor Krings, Yunn Yi Chen, David A Potter, Erica M Stringer-Reasor, Sarah L Blair, Smita M Asare, Amy Wilson, Gillian L Hirst, Ruby Singhrao, Meredith Buxton, Julia L Clennell, Ashish Sanil, Scott Berry, Adam L Asare, Jeffrey B Matthews, Angela M DeMichele, Nola M Hylton, Michelle E Melisko, Jane Perlmutter, Hope S Rugo, William Fraser Symmans, Laura van 't Veer, Douglas Yee, Donald A Berry, Laura J Esserman
Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (4) (2024)
Hope S Rugo, Sara M Tolaney, Delphine Loirat, Kevin Punie, Aditya Bardia, Sara Alsterlind Hurvitz, Joyce O'Shaughnessy, Javier Cortes, Véronique Diéras, Lisa Anne Carey, Luca Gianni, Martine J Piccart, Sibylle Loibl, David M Goldenberg, Quan Hong, Martin Olivo, Loretta M Itri, Kevin Kalinsky
Author Correction: Safety analyses from the phase 3 ASCENT trial of sacituzumab govitecan in metastatic triple-negative breast cancer. NPJ breast cancer 10 (1) (2024)
Anne Loeser, Janice S Kim, Jeffrey M Peppercorn, Mark E Burkard, Andrzej Niemierko, Dejan Juric, Kevin M Kalinsky, Hope S Rugo, Lesley Glenn, Christine Hodgdon, Julia Maués, Sheila Johnson, Natalia Padron, Kimberly Parekh, Maryam B Lustberg, Aditya Bardia
The Right Dose: Results of a Patient Advocate-Led Survey of Individuals With Metastatic Breast Cancer Regarding Treatment-Related Side Effects and Views About Dosage Assessment to Optimize Quality of Life. JCO oncology practice 20 (7) (2024)
Daniel G Stover, Roberto Salgado, Oleksander Savenkov, Karla Ballman, Erica L Mayer, Mark Jesus M Magbanua, Sherene Loi, Mark Vater, Kristyn Glover, Mark Watson, Yujia Wen, William Fraser Symmans, Charles M Perou, Lisa Anne Carey, Ann H Partridge, Hope S Rugo
Association between tumor-infiltrating lymphocytes and survival in patients with metastatic breast cancer receiving first-line chemotherapy: analysis of CALGB 40502. NPJ breast cancer 10 (1) (2024)
Mark Jesus M Magbanua, Ziad Ahmed, Rosalyn W Sayaman, Lamorna Brown Swigart, Gillian L Hirst, Christina Yau, Denise M Wolf, Wen Li, Amy L Delson, Jane Perlmutter, Paula R Pohlmann, William Fraser Symmans, Douglas Yee, Nola M Hylton, Laura J Esserman, Angela M DeMichele, Hope S Rugo, Laura van 't Veer
Cell-free DNA concentration as a biomarker of response and recurrence in HER2-negative breast cancer receiving neoadjuvant chemotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Matthew P Goetz, Irfan Cicin, Laura Testa, Sara M Tolaney, Jens Huober, Valentina Guarneri, Stephen R D Johnston, Miguel Martin, Priya Rastogi, Nadia Harbeck, Ashwin Shahir, Ran Wei, Valérie André, Hope S Rugo, Joyce O'Shaughnessy
Impact of dose reductions on adjuvant abemaciclib efficacy for patients with high-risk early breast cancer: analyses from the monarchE study. NPJ breast cancer 10 (1) (2024)
Mark Jesus M Magbanua, Ziad Ahmed, Rosalyn W Sayaman, Lamorna Brown Swigart, Gillian L Hirst, Christina Yau, Denise M Wolf, Wen Li, Amy L Delson, Jane Perlmutter, Paula R Pohlmann, William Fraser Symmans, Douglas Yee, Nola M Hylton, Laura J Esserman, Angela M DeMichele, Hope S Rugo, Laura van 't Veer
Cell-free DNA Concentration as a Biomarker of Response and Recurrence in HER2-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Hope S Rugo, Aditya Bardia, Sara M Tolaney
Reply to G.-F. Li et al, K. Altundag, and N. SG et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (8) (2023)
Curigliano Giuseppe, Geoffrey I Shapiro, Rebecca S Kristeleit, Albiruni R Abdul Razak, Stephen Leong, Maria Alsina, Antonio Giordano, Karen A Gelmon, Erica Stringer-Reasor, Ulka N Vaishampayan, Mark Ross Middleton, Anthony J Olszanski, Hope S Rugo, Kenneth A Kern, Nuzhat Pathan, Rachelle Perea, Kristen J Pierce, Sarah C Mutka, Zev A Wainberg
Correction to: A Phase 1B open-label study of gedatolisib (PF-05212384) in combination with other anti-tumour agents for patients with advanced solid tumours and triple-negative breast cancer. British journal of cancer (2023)
William J Gradishar, Ruth M O'Regan, Mothaffar F Rimawi, Jeffrey L Nordstrom, Minori K Rosales, Hope S Rugo
Margetuximab in HER2-positive metastatic breast cancer. Future oncology (London, England) (2023)
Laura A Huppert, Ozge Gumusay, Dame Idossa, Hope S Rugo
Systemic therapy for hormone receptor-positive/human epidermal growth factor receptor 2-negative early stage and metastatic breast cancer. CA: a cancer journal for clinicians (2023)
Hope S Rugo, Xianchen Liu, Benjamin Li, Lynn McRoy, Connie Chen, Rachel M Layman, Adam Brufsky
Real-world treatment patterns for palbociclib plus an aromatase inhibitor, or an aromatase inhibitor alone, for patients with metastatic breast cancer in the Flatiron Database. International journal of cancer (2023)
Sherene Loi, Roberto Salgado, Thomas Powles, Javier Cortes, David W Cescon, Eric P Winer, Deborah L Toppmeyer, Hope S Rugo, Michelino De Laurentiis, Rita Nanda, Hiroji Iwata, Ahmad Awada, Antoinette R Tan, Yuan Sun, Vassiliki Karantza, Anran Wang, Lingkang Huang, Assieh Saadatpour, Razvan Cristescu, Jennifer Yearley, Jared Lunceford, Petar Jelinic, Sylvia Adams
Association Between Biomarkers and Clinical Outcomes of Pembrolizumab Monotherapy in Patients With Metastatic Triple-Negative Breast Cancer: KEYNOTE-086 Exploratory Analysis. JCO precision oncology 7 (2023)
Hope S Rugo, Aditya Bardia, Sara M Tolaney
Reply to G.-F. Li et al, K. Altundag, and N. SG et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (8) (2023)
Hope S Rugo, Catherine H Van Poznak, Patrick Neven, Iwona Danielewicz, Soo-Chin Lee, Mario Campone, Jeannie Y K Chik, Estela Vega Alonso, Bjørn Naume, Etienne G C Brain, Jonathan M Siegel, Rui Li, Deise Uema, Volker J Wagner, Robert E Coleman
Radium-223 in women with hormone receptor-positive bone-metastatic breast cancer receiving endocrine therapy: pooled analysis of two international, phase 2, randomized, double-blind, placebo-controlled trials. Breast cancer research and treatment 204 (2) (2023)
Sherene Loi, Roberto Salgado, Thomas Powles, Javier Cortes, David W Cescon, Eric P Winer, Deborah L Toppmeyer, Hope S Rugo, Michelino De Laurentiis, Rita Nanda, Hiroji Iwata, Ahmad Awada, Antoinette R Tan, Yuan Sun, Vassiliki Karantza, Anran Wang, Lingkang Huang, Assieh Saadatpour, Razvan Cristescu, Jennifer Yearley, Jared Lunceford, Petar Jelinic, Sylvia Adams
Association Between Biomarkers and Clinical Outcomes of Pembrolizumab Monotherapy in Patients With Metastatic Triple-Negative Breast Cancer: KEYNOTE-086 Exploratory Analysis. JCO precision oncology 7 (2023)
Nicholas C Turner, A Douglas Laird, Melinda L Telli, Hope S Rugo, Audrey Mailliez, Johannes Ettl, Eva-Maria Grischke, Lida A Mina, Judith Balmaña, Peter Andreas Fasching, Sara Alsterlind Hurvitz, Julia F Hopkins, Lee A Albacker, Jijumon Chelliserry, Ying Chen, Umberto Conte, Andrew M Wardley, Mark E Robson
Genomic analysis of advanced breast cancer tumors from talazoparib-treated gBRCA1/2mut carriers in the ABRAZO study. NPJ breast cancer 9 (1) (2023)
Hope S Rugo, Catherine H Van Poznak, Patrick Neven, Iwona Danielewicz, Soo-Chin Lee, Mario Campone, Jeannie Y K Chik, Estela Vega Alonso, Bjørn Naume, Etienne G C Brain, Jonathan M Siegel, Rui Li, Deise Uema, Volker J Wagner, Robert E Coleman
Radium-223 in women with hormone receptor-positive bone-metastatic breast cancer receiving endocrine therapy: pooled analysis of two international, phase 2, randomized, double-blind, placebo-controlled trials. Breast cancer research and treatment 204 (2) (2023)
K W Im, L A Huppert, L Malevanchik, Hope S Rugo, A J Combes, Michael J Campbell, M F Krummel, M E Melisko
High-dimensional immune cell profiling of cerebrospinal fluid from patients with metastatic breast cancer and leptomeningeal disease. NPJ breast cancer 9 (1) (2023)
Laura A Huppert, Hope S Rugo
Can We De-escalate Therapy for HER2-Positive Metastatic Breast Cancer? Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Saya L Jacob, Laura A Huppert, Hope S Rugo
Role of Immunotherapy in Breast Cancer. JCO oncology practice (2023)
Fatima Cardoso, Julie Rihani, Victoria Harmer, Nadia Harbeck, Ana Casas, Hope S Rugo, Peter A Fasching, Adam Moore, Joanna de Courcy, Purnima Pathak, Sina Haftchenary, Dawn Aubel, Eva Schumacher-Wulf
Quality of Life and Treatment-Related Side Effects in Patients With HR+/HER2- Advanced Breast Cancer: Findings From a Multicountry Survey. The oncologist (2023)
Hope S Rugo, Xianchen Liu, Benjamin Li, Lynn McRoy, Connie Chen, Rachel M Layman, Adam M Brufsky
Real-World Effectiveness of Palbociclib Plus Aromatase Inhibitors in African American Patients With Metastatic Breast Cancer. The oncologist (2023)
Kathy S Albain, Christina Yau, Emanuel F Petricoin, Denise M Wolf, Julie E Lang, Amy Jo Chien, Tufia C Haddad, Andres Forero-Torres, Anne M Wallace, Henry G Kaplan, Lajos Pusztai, David M Euhus, Rita Nanda, Anthony D Elias, Amy S Clark, Constantine Godellas, Judy C Boughey, Claudine Isaacs, Debasish Tripathy, Janice Lu, Rachel L Yung, Rosa I Gallagher, Julia D Wulfkuhle, Lamorna Brown Swigart, Gregor Krings, Yunn Yi Chen, David A Potter, Erica M Stringer-Reasor, Sarah L Blair, Smita M Asare, Amy Wilson, Gillian L Hirst, Ruby Singhrao, Meredith Buxton, Julia L Clennell, Ashish Sanil, Scott Berry, Adam L Asare, Jeffrey B Matthews, Angela M DeMichele, Nola M Hylton, Michelle E Melisko, Jane Perlmutter, Hope S Rugo, William Fraser Symmans, Laura van 't Veer, Douglas Yee, Donald A Berry, Laura J Esserman
Neoadjuvant trebananib plus paclitaxel-based chemotherapy for stage II/III breast cancer in the adaptively randomized I-SPY2 trial - Efficacy and biomarker discovery. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Hope S Rugo, Catherine H Van Poznak, Patrick Neven, Iwona Danielewicz, Soo-Chin Lee, Mario Campone, Jeannie Y K Chik, Estela Vega Alonso, Bjørn Naume, Etienne G C Brain, Jonathan M Siegel, Rui Li, Deise Uema, Volker J Wagner, Robert E Coleman
Radium-223 in women with hormone receptor-positive bone-metastatic breast cancer receiving endocrine therapy: pooled analysis of two international, phase 2, randomized, double-blind, placebo-controlled trials. Breast cancer research and treatment 204 (2) (2023)
Hope S Rugo, Christine L Crossno, Yaron B Gesthalter, Kristen Kelley, Heather B Moore, Mothaffar F Rimawi, Kelly E Westbrook, Saundra S Buys
Real-World Perspectives and Practices for Pneumonitis/Interstitial Lung Disease Associated With Trastuzumab Deruxtecan Use in Human Epidermal Growth Factor Receptor 2-Expressing Metastatic Breast Cancer. JCO oncology practice (2023)
Jennifer K Litton, Meredith M Regan, Lajos Pusztai, Hope S Rugo, Sara M Tolaney, Elizabeth Garrett-Mayer, Laleh Amiri-Kordestani, Reva K Basho, Ana F Best, Jean-Francois Boileau, Carsten Denkert, Jared C Foster, Nadia Harbeck, Heather A Jacene, Tari A King, Ginny Mason, Ciara Catherine O'Sullivan, Tatiana M Prowell, Andrea L Richardson, Karla A Sepulveda, Mary Lou Smith, Judy A Tjoe, Gulisa Turashvili, Wendy A Woodward, Lynn Pearson Butler, Elena I Schwartz, Larissa A Korde
Standardized Definitions for Efficacy End Points in Neoadjuvant Breast Cancer Clinical Trials: NeoSTEEP. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Ozge Gumusay, Laura A Huppert, Mark Jesus M Magbanua, Chiara A Wabl, Michael Assefa, Amy Jo Chien, Michelle E Melisko, Melanie C Majure, Mark Moasser, John Park, Hope S Rugo
A phase Ib/II study of eribulin in combination with cyclophosphamide in patients with advanced breast cancer. Breast cancer research and treatment (2023)
Hope S Rugo, Aditya Bardia, Sara M Tolaney
Reply to G.-F. Li et al, K. Altundag, and N. SG et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Hope S Rugo, Catherine H Van Poznak, Patrick Neven, Iwona Danielewicz, Soo-Chin Lee, Mario Campone, Jeannie Y K Chik, Estela Vega Alonso, Bjørn Naume, Etienne G C Brain, Jonathan M Siegel, Rui Li, Deise Uema, Volker J Wagner, Robert E Coleman
Radium-223 in women with hormone receptor-positive bone-metastatic breast cancer receiving endocrine therapy: pooled analysis of two international, phase 2, randomized, double-blind, placebo-controlled trials. Breast cancer research and treatment 204 (2) (2023)
Helena Record, Elle Clelland, Harriet T Rothschild, Mandeep Kaur, A Jo Chien, Michelle Melisko, Hope S Rugo, Firdows Mujir, Laura Huppert, Rita A Mukhtar
Tamoxifen or aromatase inhibitors with ovarian function suppression in pre-menopausal stage I-III lobular breast cancer. NPJ breast cancer 9 (1) (2023)
Hope S Rugo, Catherine H Van Poznak, Patrick Neven, Iwona Danielewicz, Soo-Chin Lee, Mario Campone, Jeannie Y K Chik, Estela Vega Alonso, Bjørn Naume, Etienne G C Brain, Jonathan M Siegel, Rui Li, Deise Uema, Volker J Wagner, Robert E Coleman
Radium-223 in women with hormone receptor-positive bone-metastatic breast cancer receiving endocrine therapy: pooled analysis of two international, phase 2, randomized, double-blind, placebo-controlled trials. Breast cancer research and treatment (2023)
Hope S Rugo, Adam M Brufsky, Xianchen Liu, Benjamin Li, Lynn McRoy, Connie Chen, Rachel M Layman, Massimo Cristofanilli, Mylin A Torres, Curigliano Giuseppe, Richard S Finn, Angela DeMichele
Real-world study of overall survival with palbociclib plus aromatase inhibitor in HR+/HER2- metastatic breast cancer. NPJ breast cancer 8 (1) (2022)
Julie E Lang, Andres Forero-Torres, Douglas Yee, Christina Yau, Denise Wolf, John Park, Barbara A Parker, A Jo Chien, Anne M Wallace, Rashmi Murthy, Kathy S Albain, Erin D Ellis, Heather Beckwith, Barbara B Haley, Anthony D Elias, Judy C Boughey, Rachel L Yung, Claudine Isaacs, Amy S Clark, Hyo S Han, Rita Nanda, Qamar J Khan, Kristen K Edmiston, Erica Stringer-Reasor, Elissa Price, Bonnie Joe, Minetta C Liu, Lamorna Brown Swigart, Emanuel F Petricoin, Julia D Wulfkuhle, Meredith Buxton, Julia L Clennell, Ashish Sanil, Scott Berry, Smita M Asare, Amy Wilson, Gillian L Hirst, Ruby Singhrao, Adam L Asare, Jeffrey B Matthews, Michelle Melisko, Jane Perlmutter, Hope S Rugo, William Fraser Symmans, Laura van 't Veer, Nola M Hylton, Angela M DeMichele, Donald A Berry, Laura J Esserman
Safety and efficacy of HSP90 inhibitor ganetespib for neoadjuvant treatment of stage II/III breast cancer. NPJ breast cancer 8 (1) (2022)
Joyce V Lee, Filomena Housley, Christina Yau, Rachel Nakagawa, Juliane Winkler, Johanna M Anttila, Pauliina M Munne, Mariel Savelius, Kathleen E Houlahan, Daniel Van de Mark, Golzar Hemmati, Grace A Hernandez, Yibing Zhang, Susan Samson, Carole Baas, Marleen Kok, Laura J Esserman, Laura van 't Veer, Hope S Rugo, Christina Curtis, Juha Klefström, Mehrdad Matloubian, Andrei Goga
Author Correction: Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer. Nature communications 13 (1) (2022)
Jung-Tung Hung, I-Ju Chen, Shir-Hwa Ueng, Chiun-Sheng Huang, Shin-Cheh Chen, Mu-Yi Chen, Yung-Chang Lin, Yung-Chang Lin, Michael J Campbell, Hope S Rugo, Alice Lin-Tsing Yu
The clinical relevance of humoral immune responses to Globo H-KLH vaccine adagloxad simolenin (OBI-822)/OBI-821 and expression of Globo H in metastatic breast cancer. Journal for immunotherapy of cancer 10 (6) (2022)
Hope S Rugo, Javier Cortes, Carlos H Barrios, Paula Cabrera, Binghe Xu, Chiun-Sheng Huang, Sung-Bae Kim, Michelle Melisko, Rita Nanda, Tadeusz Pieńkowski, Bernardo L Rapoport, Richard Schwab
GLORIA: phase III, open-label study of adagloxad simolenin/OBI-821 in patients with high-risk triple-negative breast cancer. Future oncology (London, England) (2022)
Hope S Rugo, Aditya Bardia, Frederic Marmé, Javier Cortes, Peter Schmid, Delphine Loirat, Olivier Trédan, Eva Ciruelos Gil, Florence Dalenc, Patricia Gómez Pardo, Komal L Jhaveri, Rosemary Delaney, Olivia Fu, Lanjia Lin, Wendy Verret, Sara M Tolaney
Sacituzumab Govitecan in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (29) (2022)

Hope S Rugo.css-eqlu8i{font-size:small;padding-left:4px;} (Hope Rugo, H S Rugo)

Publication Activity (10 Years)

Top Topics

Top Venues

Hope S Rugo (Hope Rugo, H S Rugo)